Latest Posts
- $2 Million SBIR direct to phase II award funds therapeutic development and testing at... October 04, 2022
- TGen, ASU, and Phoenix Children’s collaborate to better diagnose and treat disease af... September 28, 2022
- Deep Proteomic Profiling Reveals Possible Therapeutic Targets for Medulloblastoma September 26, 2022
Useful Links
Contact Us
445 N. Fifth Street
Phoenix, AZ 85004
Phone: 602.343.8400
Toll Free: +1-866-370-8436
Stay up-to-date with TGen
2022 © All Rights Reserved TGen. Registered 501(c)(3). EIN: 75-3065445